News
The new guidance on vaccines, such as those that protect against COVID-19, influenza, and RSV, will be released by the end of the summer, ahead of respiratory season.
The single-arm, open-label DR-OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who are at risk for pregnancy or desiring contraception.
"If immunotherapy eliminates most of the tumor before surgery, then we have sufficiently trained the immune system for an antitumor response, which minimizes the possibility of recurrence," said lead ...
The new method, which is illegal in the United States but approved in Britain since 2015, adds a tiny bit of healthy mitochondrial DNA from a donor’s egg to the mix, with more than 99% of the child’s ...
Researchers analyzed hospital inpatient data to evaluate the risk for vascular events on the basis of PCOS among women with thrombotic disease.
Researchers conducted an observational study to assess the effect of osteoporosis treatment on mortality risk among patients ...
For most heat-specific encounters, patients were discharged from the emergency department (96%), while most rhabdomyolysis encounters resulted in admission (63%). HealthDay News — Heat-related ...
The population analysis included 99,411 women with premenstrual disorders, and the sibling analysis included 36,061 women with premenstrual disorders.
The most prevalent symptom of discontinuation was dizziness, and, despite being measured in people with major depressive disorder, discontinuation was not associated with depression symptoms.
Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results